The Effect of Standardized Withania Somnifera Extract on Endocrine, Metabolic, and Psychometric Parameters, in Women With Polyendocrine Metabolic Ovarian Syndrome

The objective of this study is to ascertain the impact of a standardized Withaniasomnifera extract on endocrine, metabolic, and psychometric parameters in women diagnosedwith polyendocrine metabolic ovarian syndrome. The assessment will encompass a range ofparameters to determine the severity of depression, stress levels, the quality of sleep,blood pressure, body mass index, and body composition. Additionally, biochemical,metabolic, and endocrine blood parameters in serum will be analysed.The trial's findings may yield a safe and easy‐to‐use method of adjunctive treatment thatcould complement therapy in patients with polycystic ovary syndrome.